You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 9, March 1, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Lab, Field, & Clinic
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Genetics
 •Genetic Disorders
 •Hematology/ Hematologic Malignancies
 •Anemias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Yuet Wai Kan, MD

Sickle Cell and Thalassemia Pioneer

Tracy Hampton, PhD

JAMA. 2006;295:991.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Sickle cell disease and thalassemia, inherited disorders of hemoglobin, constitute the most common genetic diseases in the world, and aggressive lifelong treatments are required for managing the anemia and other painful complications that accompany them.

Yuet Wai Kan, MD, of the University of California, San Francisco, has led the way in the study and treatment of these diseases. In the mid-1970s, he discovered the genetic mutations in the {alpha}- and beta-globin genes that cause {alpha}- and beta-thalassemia, respectively. He also ushered in the era of genetic testing for diseases by discovering DNA analysis techniques for tracing the transmission of disease-causing genes in families.


Figure 600001
Yuet Wai Kan, MD (Photo credit: Yuet Wai Kan, MD/Anthony Buckley & Constantine)

Kan has won many awards, most notably the Albert Lasker Clinical Medical Research Award in 1991. Today he continues to make contributions with his research on potential treatments for these diseases. . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.